口腔鳞状细胞癌组织中差异微小RNA/mRNA表达谱的对接研究(4)
 |
| 第1页 |
参见附件。
[18]Wong TS， Liu XB， Wong BY， et al. Mature miR-184 as po-tential oncogenic microRNA of squamous cell carcinoma of tongue[J]. Clin Cancer Res， 2008， 14(9)：2588-2592.
[19]Lu YC， Chen YJ， Wang HM， et al. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling[J]. Cancer Prev Res： Phila， 2012， 5(4)：665-674.
[20]Minor J， Wang X， Zhang F， et al. Methylation of micro-RNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas[J]. Oral Oncol， 2012， 48(1)：73-78.
[21]Yan B， Fu Q， Lai L， et al. Downregulation of microRNA 99a in oral squamous cell carcinomas contributes to the growth and survival of oral cancer cells[J]. Mol Med Rep， 2012， 6
(3)：675-681.
[22]Henson BJ， Bhattacharjee S， O’Dee DM， et al. Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy[J]. Genes Chromosomes Cancer， 2009， 48(7)：569-582.
[23]Harris T， Jimenez L， Kawachi N， et al. Low-level expression of miR-375 correlates with poor outcome and metastasis while altering the invasive properties of head and neck squa-mous cell carcinomas[J]. Am J Pathol， 2012， 180(3)：917-928.
[24]Wang W， Songlin P， Sun Y， et al. miR-21 inhibitor sensitizes human OSCC cells to cisplatin[J]. Mol Biol Rep， 2012， 39
(5)：5481-5485.
[25]Liu CJ， Lin SC， Yang CC， et al. Exploiting salivary miR-31 as a clinical biomarker of oral squamous cell carcinoma[J]. Head Neck， 2012， 34(2)：219-224.
(本文编辑 杜冰)
您现在查看是摘要介绍页，详见PDF附件。